209 related articles for article (PubMed ID: 18443267)
1. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.
Killie MK; Husebekk A; Kjeldsen-Kragh J; Skogen B
Haematologica; 2008 Jun; 93(6):870-7. PubMed ID: 18443267
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.
Kjeldsen-Kragh J; Titze TL; Lie BA; Vaage JT; Kjær M
Blood Adv; 2019 Apr; 3(7):945-951. PubMed ID: 30923048
[TBL] [Abstract][Full Text] [Related]
3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
4. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.
Williamson LM; Hackett G; Rennie J; Palmer CR; Maciver C; Hadfield R; Hughes D; Jobson S; Ouwehand WH
Blood; 1998 Oct; 92(7):2280-7. PubMed ID: 9746765
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
[TBL] [Abstract][Full Text] [Related]
6. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
[TBL] [Abstract][Full Text] [Related]
7. Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome.
Kjeldsen-Kragh J; Fergusson DA; Kjaer M; Lieberman L; Greinacher A; Murphy MF; Bussel J; Bakchoul T; Corke S; Bertrand G; Oepkes D; Baker JM; Hume H; Massey E; Kaplan C; Arnold DM; Baidya S; Ryan G; Savoia HF; Landry D; Shehata N
Blood Adv; 2020 Jul; 4(14):3368-3377. PubMed ID: 32717028
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.
Peterson JA; Kanack A; Nayak D; Bougie DW; McFarland JG; Curtis BR; Aster RH
Transfusion; 2013 Jun; 53(6):1309-18. PubMed ID: 23003125
[TBL] [Abstract][Full Text] [Related]
9. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
Sainio S; Javela K; Tuimala J; Haimila K
Br J Haematol; 2017 Jan; 176(1):111-117. PubMed ID: 27748520
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
Ahlen MT; Heide G; Husebekk A; Skogen B; Kjeldsen-Kragh J; Stuge TB
Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
[TBL] [Abstract][Full Text] [Related]
11. Fetomaternal alloimmune thrombocytopenia.
Ahya R; Turner ML; Urbaniak SJ;
Transfus Apher Sci; 2001 Oct; 25(2):139-45. PubMed ID: 11761276
[TBL] [Abstract][Full Text] [Related]
12. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
Kjeldsen-Kragh J; Ahlen MT
Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201.
L'Abbé D; Tremblay L; Filion M; Busque L; Goldman M; Décary F; Chartrand P
Hum Immunol; 1992 Jun; 34(2):107-14. PubMed ID: 1358865
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia.
Sainio S; Javela K; Tuimala J; Koskinen S
Transfus Med; 2013 Apr; 23(2):114-20. PubMed ID: 23448161
[TBL] [Abstract][Full Text] [Related]
15. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
Jackson DJ; Eastlake JL; Kumpel BM
Clin Exp Immunol; 2014 Apr; 176(1):23-36. PubMed ID: 24261689
[TBL] [Abstract][Full Text] [Related]
16. Maternal alloimmune antibodies against HPA and HLA class I antigens are associated with reduced birthweight among healthy neonates delivered by Chinese women.
Xue Y; Xin W; Li C; Zeng X; Song Z; Cao C; Zhao T
Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1215-1219. PubMed ID: 35871773
[TBL] [Abstract][Full Text] [Related]
17. Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.
Kjær M; Tiller H; Heide G; Kjeldsen-Kragh J; Skogen B; Husebekk A
PLoS One; 2017; 12(8):e0182957. PubMed ID: 28837581
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
Loewenthal R; Rosenberg N; Kalt R; Dardik R; Landau M; Yahalom V; Avishai O; Frenkel O; Gazit E; Steinberg DM; Lipitz S; Salomon O
Transfusion; 2013 Feb; 53(2):344-52. PubMed ID: 22671039
[TBL] [Abstract][Full Text] [Related]
19. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.
Turner ML; Bessos H; Fagge T; Harkness M; Rentoul F; Seymour J; Wilson D; Gray I; Ahya R; Cairns J; Urbaniak S
Transfusion; 2005 Dec; 45(12):1945-56. PubMed ID: 16371049
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).
Bessos H; Killie MK; Matviyenko M; Husebekk A; Urbaniak SJ
Transfus Apher Sci; 2008 Dec; 39(3):221-7. PubMed ID: 18945639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
